BOYD JEFFERY H 4

What Happened
Jeffery H. Boyd, a director of Oscar Health, received an award of 3,610 deferred stock units (derivative security) on April 9, 2026. The units were valued at $14.54 each, for a total reported value of $52,489. This was a grant of director compensation (not an open-market purchase or sale).

Key Details

• Transaction date: April 9, 2026; reported on Form 4 filed April 13, 2026 (timely filed).
• Instrument: Deferred stock units (derivative award), transaction code A (award).
• Quantity and price: 3,610 units × $14.54 = $52,489 (price equals the April 9 closing share price).
• Shares owned after transaction: Not disclosed in this filing (the filing reports the number of deferred units granted).
• Footnotes:
  • Each deferred stock unit represents a right to receive one share of Class A common stock.
  • Units will be settled for cash or shares, at the company’s discretion, within 45 days after termination of service, a change in control, death, or disability.
  • These units were issued in lieu of a cash retainer under the company’s deferred compensation plan for directors and are 100% vested on the grant date.

Context
This is routine director compensation (deferred stock units issued instead of cash retainer) and not an open-market purchase or sale. Deferred stock units are a promise to deliver shares or cash later and do not represent immediately transferable common stock. Such awards are typically administrative/compensation events rather than direct signals of the insider’s view on the stock.